menu
    • menu

    Company profile for Ergomed

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ergomed is a global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial manageme...
    Ergomed is a global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO). The Ergomed group employs over 1,500 people and operates out of 20 offices around the world, providing its services in around 100 countries globally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ergomedunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    1 Occam Court, The Surrey Research Park Guildford, Surrey GU2 7HJ
    Telephone
    Telephone
    +44 (0)1483 503 205
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ergomedplc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ergomed-clinical-research/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ergomedplc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ergomed strongly positioned for future growth in new partnership with Permira
    Ergomed strongly positioned for future growth in new partnership with Permira

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2779745/0/en/Ergomed-strongly-positioned-for-future-growth-in-new-partnership-with-Permira.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    Ergomed Rare Disease Innovation Center to Leverage Medidata Patient Cloud
    Ergomed Rare Disease Innovation Center to Leverage Medidata Patient Cloud

    05 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220505005244/en

    BUSINESSWIRE
    05 May 2022
    Share Share
    Lokavant Teams with ERGOMED's Rare Disease Clinical Innovation Center™
    Lokavant Teams with ERGOMED's Rare Disease Clinical Innovation Center™

    19 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lokavant-teams-with-ergomeds-rare-disease-clinical-innovation-center-301528431.html

    PRNEWSWIRE
    19 Apr 2022
    Share Share
    mdgroup to partner with ERGOMED on new Rare Disease Innovation Center
    mdgroup to partner with ERGOMED on new Rare Disease Innovation Center

    28 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mdgroup-to-partner-with-ergomed-on-new-rare-disease-innovation-center-301491506.html

    PRNEWSWIRE
    28 Feb 2022
    Share Share
    ERGOMED announces launch of its Rare Disease Innovation Center™
    ERGOMED announces launch of its Rare Disease Innovation Center™

    28 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/ergomed-announces-launch-of-its-rare-disease-innovation-center-301491490.html

    PRNEWSWIRE
    28 Feb 2022
    Share Share
    Ergomed Acquires MedSource
    Ergomed Acquires MedSource

    16 Dec 2020

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-12-15/ergomed-acquires-medsource/

    CONTRACTPHARMA
    16 Dec 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search